Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 10950

1.

Acne vulgaris.

[No authors listed]

Nat Rev Dis Primers. 2015 Sep 17;1:15033. doi: 10.1038/nrdp.2015.33. No abstract available.

PMID:
27227877
2.

Topical, Biological and Clinical Challenges in the Management of Patients with Acne Vulgaris.

Al-Hammadi A, Al-Ismaily A, Al-Ali S, Ramadurai R, Jain R, McKinley-Grant L, Mughal TI.

Sultan Qaboos Univ Med J. 2016 May;16(2):e152-60. doi: 10.18295/squmj.2016.16.02.004. Epub 2016 May 15. Review.

PMID:
27226905
3.

Evaluation of anti-acne property of purified bee venom serum in humans.

Han SM, Pak SC, Nicholls YM, Macfarlane N.

J Cosmet Dermatol. 2016 May 24. doi: 10.1111/jocd.12227. [Epub ahead of print]

PMID:
27216488
4.

Relationship between acne vulgaris and attention-deficit/hyperactivity disorder symptoms in a clinical sample of women.

Bilgic A, Bilgic Ö, Çolak RS, Altınyazar HC.

An Bras Dermatol. 2016 Apr;91(2):250-2. doi: 10.1590/abd1806-4841.20164613.

5.

3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems.

Goyanes A, Det-Amornrat U, Wang J, Basit AW, Gaisford S.

J Control Release. 2016 May 14;234:41-48. doi: 10.1016/j.jconrel.2016.05.034. [Epub ahead of print]

PMID:
27189134
6.

Use of topical retinoids by dermatologists and non-dermatologists in the management of acne vulgaris.

Pena S, Hill D, Feldman SR.

J Am Acad Dermatol. 2016 Jun;74(6):1252-4. doi: 10.1016/j.jaad.2016.01.011. No abstract available.

PMID:
27185427
7.

Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results.

Shemer A, Shiri J, Mashiah J, Farhi R, Gupta AK.

J Am Acad Dermatol. 2016 Jun;74(6):1251-2. doi: 10.1016/j.jaad.2015.09.065. No abstract available.

8.

Comparison effect of azithromycin gel 2% with clindamycin gel 1% in patients with acne.

Mokhtari F, Faghihi G, Basiri A, Farhadi S, Nilforoushzadeh M, Behfar S.

Adv Biomed Res. 2016 Apr 19;5:72. doi: 10.4103/2277-9175.180641. eCollection 2016.

9.

Multicenter study for efficacy and safety evaluation of a fixeddose combination gel with adapalen 0.1% and benzoyl peroxide 2.5% (Epiduo® for the treatment of acne vulgaris in Brazilian population.

Sittart JA, Costa Ad, Mulinari-Brenner F, Follador I, Azulay-Abulafia L, Castro LC.

An Bras Dermatol. 2015 Dec;90(6 Suppl 1):1-16. doi: 10.1590/abd1806-4841.20153969.

10.

Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials.

Stein Gold LF, Jarratt MT, Bucko AD, Grekin SK, Berlin JM, Bukhalo M, Weiss JS, Berk DR, Chang-Lin JE, Lin V, Kaoukhov A.

J Drugs Dermatol. 2016 May 1;15(5):553-61.

PMID:
27168264
11.

The safety of isotretinoin in patients with lupus nephritis: a comprehensive review.

Miziołek B, Bergler-Czop B, Stańkowska A, Brzezińska-Wcisło L.

Cutan Ocul Toxicol. 2016 May 10:1-8. [Epub ahead of print]

PMID:
27160965
12.

Somatic Mutations in NEK9 Cause Nevus Comedonicus.

Levinsohn JL, Sugarman JL; Yale Center for Mendelian Genomics, McNiff JM, Antaya RJ, Choate KA.

Am J Hum Genet. 2016 May 5;98(5):1030-7. doi: 10.1016/j.ajhg.2016.03.019.

PMID:
27153399
13.

Isotretinoin use for acne vulgaris is associated with increased serum uric acid levels.

Solak B, Erdem T, Solak Y.

J Dermatolog Treat. 2016 May 6:1-4. [Epub ahead of print]

PMID:
27151312
14.

Acne and Nutrition: A Systematic Review.

Fiedler F, Stangl GI, Fiedler E, Taube KM.

Acta Derm Venereol. 2016 May 3. doi: 10.2340/00015555-2450. [Epub ahead of print]

15.

Solid lipid microparticles for enhanced dermal delivery of tetracycline HCl.

Rahimpour Y, Javadzadeh Y, Hamishehkar H.

Colloids Surf B Biointerfaces. 2016 Apr 22;145:14-20. doi: 10.1016/j.colsurfb.2016.04.034. [Epub ahead of print]

PMID:
27131093
16.

Absence or low density of P. acnes in comedonal lesions of acne patients? A surface to inside study of skin fluorescence.

Xu DT, Qi XL, Cui Y, Liu W.

Exp Dermatol. 2016 Apr 29. doi: 10.1111/exd.13045. [Epub ahead of print]

PMID:
27125260
17.

Energy-Based Devices in Treatment of Acne Vulgaris.

Handler MZ, Bloom BS, Goldberg DJ.

Dermatol Surg. 2016 May;42(5):573-85. doi: 10.1097/DSS.0000000000000715.

PMID:
27110894
18.

Pro-inflammatory sebocyte growth and survival signaling in acne vulgaris is reversed by pro-apoptotic isotretinoin signaling.

Melnik BC.

Exp Dermatol. 2016 Apr 20. doi: 10.1111/exd.13032. [Epub ahead of print]

PMID:
27095186
19.

Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrheic skin and acne treatment.

Oláh A, Markovics A, Szabó-Papp J, Szabó PT, Stott C, Zouboulis CC, Bíró T.

Exp Dermatol. 2016 Apr 20. doi: 10.1111/exd.13042. [Epub ahead of print]

PMID:
27094344
20.

Photodynamic therapy for the treatment of different severity of acne: A systematic review.

Keyal U, Bhatta AK, Wang XL.

Photodiagnosis Photodyn Ther. 2016 Apr 15. pii: S1572-1000(16)30033-3. doi: 10.1016/j.pdpdt.2016.04.005. [Epub ahead of print] Review.

PMID:
27090488
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk